Groundbreaking robotic surgery aims to preserve erections
About 13% of American men will develop prostate cancer at some point, putting their erectile function at risk.
Goodbye, flop era!
Prostate cancer is the most common cancer among men in the US, aside from skin cancer. About 13% of male Americans will get it — and treatment often comes with the risk of erectile dysfunction.
Relief is coming — the world’s first dual-robotic surgery to remove a prostate gland was performed last month in Texas. This groundbreaking approach aims to preserve the nerves that control erectile function.
“We have a magnetic technology that enables better retraction of the tissues and better visualization,” Dr. Alberto Rodriguez-Navarro, founder and CEO of Levita Magnetics, told The Post.
“In the case of the prostate, this might result in the surgeon better seeing the nerve bundles,” Rodriguez-Navarro continued. “The nerves are very important because they are related to incontinence, like urinary incontinence, and also sexual function, so preserving those nerves is critical.”